当前位置: X-MOL 学术Biomater. Sci. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
A dimeric α-helical cell penetrating peptide mounted with an HER2-selective affibody
Biomaterials Science ( IF 5.8 ) Pub Date : 2021-08-12 , DOI: 10.1039/d1bm00819f
Seung-Eun Chong 1 , Donghyun Lee 2 , Jae Hoon Oh 3 , Sunyoung Kang 1 , Sejong Choi 1 , So Hee Nam 1 , Jaehoon Yu 4 , Heebeom Koo 2 , Yan Lee 1
Affiliation  

We have developed a cell penetrating peptide (CPP) system with high selectivity and penetrability at nanomolar concentrations with a combination of an HER2-selective affibody, ZHER2:342 (ZHER2), and a dimeric α-helical leucine- and lysine-rich peptide, LK-2. ZHER2 and LK-2 are linearly fused together and expressed in a prokaryotic system to create the LK-2-ZHER2 protein, which can successfully distinguish and penetrate HER2-overexpressing cancer cells at nanomolar concentrations. LK-2-ZHER2 has the ability to intracellularly deliver doxorubicin as a conjugate form to enhance its anti-cancer effect on HER2-overexpressing breast cancer cells with a great selectivity. The selective penetrability was confirmed in vitro, in 3D spheroids, and in in vivo models. LK-2-ZHER2 has the capability to overcome the weak points of current CPPs, such as poor penetrability at low concentrations and a lack of selectivity, by combining powerful CPP and affibody sequences.

中文翻译:

带有 HER2 选择性 affibody 的二聚体 α-螺旋细胞穿透肽

我们开发了一种细胞穿透肽 (CPP) 系统,该系统在纳摩尔浓度下具有高选择性和穿透性,并结合了 HER2 选择性亲和体 Z HER2:342 (Z HER2 ) 和富含 α-螺旋富含亮氨酸和赖氨酸的二聚体肽,LK-2。Z HER2和 LK-2 线性融合在一起并在原核系统中表达以产生 LK-2-Z HER2蛋白,该蛋白可以在纳摩尔浓度下成功区分和穿透过表达 HER2 的癌细胞。LK-2-Z HER2能够以偶联物形式在细胞内递送阿霉素,以增强其对 HER2 过表达乳腺癌细胞的抗癌作用,具有很高的选择性。选择性渗透性得到证实体外、3D 球体和体内模型。LK-2-Z HER2通过结合强大的 CPP 和 affibody 序列,能够克服当前 CPP 的弱点,例如低浓度渗透性差和缺乏选择性。
更新日期:2021-08-26
down
wechat
bug